PH Stock Analysis: Parker-Hannifin | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 121.809m USD | 12M Return: 26.8% | US7010941042 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 500M
EPS Trend: 98.3%
Qual. Beats: 5
Rev. Trend: 79.1%
Qual. Beats: 5
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Parker-Hannifin Corporation (NYSE: PH) is a U.S.-based manufacturer of motion and control technologies serving aerospace and defense, industrial, transportation, off-highway, energy, and HVAC/refrigeration markets across North America, EMEA, Asia Pacific, and Latin America. The company operates through two segments: Diversified Industrial and Aerospace Systems. Classified within the Industrials sector (GICS Sub-Industry: Industrial Machinery & Supplies & Components), PH operates as a large-cap industrial component supplier with a diversified end-market footprint.
Its product portfolio spans motion-control systems and components, including vibration control, sealing solutions, filtration, pumps, motors, valves, actuators, drives, sensors, fluid conveyance, thermal management, and structural adhesives. These products address both industrial fluid power and pneumatic applications as well as specialized aerospace requirements, reflecting the breadth typical of broad-line industrial component manufacturers.
In aerospace and defense, PH supplies components for commercial and military airframe and engine programs, including avionics, braking systems, flight controls, fuel systems, hydraulics, pneumatics, seals, and thermal management products. The company distributes through original equipment manufacturers, distributors, and a direct sales force. Founded in 1917 and headquartered in Cleveland, Ohio, Parker-Hannifin has over a century of operating history in industrial manufacturing.
- Meggitt integration synergies expand aerospace segment margins
- Diversified Industrial orders decline on weakening global manufacturing PMI
- Win Strategy pricing actions sustain margins amid input cost inflation
| Net Income: 3.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.32 > 1.0 |
| NWC/Revenue: 7.44% < 20% (prev 5.70%; Δ 1.74% < -1%) |
| CFO/TA 0.14 > 3% & CFO 4.36b > Net Income 3.65b |
| Net Debt (8.23b) to EBITDA (5.81b): 1.42 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.8m) vs 12m ago -0.93% < -2% |
| Gross Margin: 37.69% > 18% (prev 36.93%; Δ 0.75% > 0.5%) |
| Asset Turnover: 71.22% > 50% (prev 67.30%; Δ 3.92% > 0%) |
| Interest Coverage Ratio: 12.38 > 6 (EBIT TTM 4.96b / Interest Expense TTM 401.0m) |
| A: 0.05 (Total Current Assets 7.70b - Total Current Liabilities 6.10b) / Total Assets 30.9b |
| B: 0.79 (Retained Earnings 24.5b / Total Assets 30.9b) |
| C: 0.16 (EBIT TTM 4.96b / Avg Total Assets 30.2b) |
| D: 1.00 (Book Value of Equity 15.4b / Total Liabilities 15.5b) |
| Altman-Z'' = 5.08 = AAA |
| DSRI: 1.00 (Receivables 3.67b/3.38b, Revenue 21.5b/19.9b) |
| GMI: 0.98 (GM 36.93% / 37.69%) |
| AQI: 0.97 (AQ_t 0.65 / AQ_t-1 0.66) |
| SGI: 1.08 (Revenue 21.5b / 19.9b) |
| TATA: -0.02 (NI 3.65b - CFO 4.36b) / TA 30.9b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of October 09, 2026, the stock is trading at USD 946.96 with a total of 541,809 shares traded. Over the past week, the price has changed by -1.96%, over one month by -0.93%, over three months by +1.04% and over the past year by +26.75%.
Current recommended Stop Loss: 919.80 (which is 2.9% or 1.3 ATR below the current price).
Parker-Hannifin has received a consensus analysts rating of 4.27. Therefore, it is recommended to buy PH.
- StrongBuy: 16
- Buy: 3
- Hold: 6
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 1155.3 | 22% |
P/E Trailing = 33.5608
P/E Forward = 27.4725
P/S = 5.6658
P/B = 7.8992
P/EG = 3.2312
Revenue TTM = 21.5b USD
EBIT TTM = 4.96b USD
EBITDA TTM = 5.81b USD
Long Term Debt = 6.77b USD (from longTermDebt, last quarter)
Short Term Debt = 1.80b USD (from shortTermDebt, last quarter)
Debt = 8.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.23b USD (calculated: Debt 8.73b - CCE 501.0m)
Enterprise Value = 130b USD (122b + Debt 8.73b - CCE 501.0m)
Interest Coverage Ratio = 12.38 (Ebit TTM 4.96b / Interest Expense TTM 401.0m)
EV/FCF = 33.30x (Enterprise Value 130b / FCF TTM 3.90b)
FCF Yield = 3.00% (FCF TTM 3.90b / Enterprise Value 130b)
FCF Margin = 18.16% (FCF TTM 3.90b / Revenue TTM 21.5b)
Net Margin = 16.97% (Net Income TTM 3.65b / Revenue TTM 21.5b)
Gross Margin = 37.69% ((Revenue TTM 21.5b - Cost of Revenue TTM 13.4b) / Revenue TTM)
Gross Margin QoQ = 39.04% (prev 36.77%)
Tobins Q-Ratio = 4.21 (Enterprise Value 130b / Total Assets 30.9b)
Interest Expense / Debt = 4.59% (Interest Expense 401.0m / Debt 8.73b)
Taxrate = 20.03% (914.0m / 4.56b)
NOPAT = 3.97b (EBIT 4.96b * (1 - 20.03%))
Current Ratio = 1.26 (Total Current Assets 7.70b / Total Current Liabilities 6.10b)
Debt / Equity = 0.57 (Debt 8.73b / totalStockholderEquity, last quarter 15.4b)
Debt / EBITDA = 1.42 (Net Debt 8.23b / EBITDA 5.81b)
Debt / FCF = 2.11 (Net Debt 8.23b / FCF TTM 3.90b)
Total Stockholder Equity = 14.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.09% (Net Income 3.65b / Total Assets 30.9b)
RoE = 25.11% (Net Income TTM 3.65b / Total Stockholder Equity 14.5b)
RoCE = 23.31% (EBIT 4.96b / Capital Employed (Equity 14.5b + L.T.Debt 6.77b))
RoIC = 15.22% (NOPAT 3.97b / Invested Capital 26.1b)
WACC = 9.78% (E(122b)/V(131b) * Re(10.22%) + D(8.73b)/V(131b) * Rd(4.59%) * (1-Tc(0.20)))
Discount Rate = 10.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.07 | Cagr: -0.96%
[DCF] Terminal Value 73.48% ; FCFF base≈3.68b ; Y1≈4.22b ; Y5≈6.21b
[DCF] Fair Price = 526.0 (EV 74.6b - Net Debt 8.23b = Equity 66.3b / Shares 126.1m; r=9.78% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.33 | EPS CAGR: 11.93% | SUE: 4.0 | # QB: 5
Revenue Correlation: 79.15 | Revenue CAGR: 2.41% | SUE: 2.35 | # QB: 5
EPS current Quarter (2026-09-30): EPS=8.14 | Chg30d=+0.21% | Revisions=+50% | Analysts=13
EPS next Quarter (2026-12-31): EPS=8.49 | Chg30d=+0.49% | Revisions=+50% | Analysts=13
EPS current Year (2027-06-30): EPS=35.52 | Chg30d=+0.52% | Revisions=+67% | GrowthEPS=+9.9% | GrowthRev=+14.0%
EPS next Year (2028-06-30): EPS=39.42 | Chg30d=+0.57% | Revisions=+57% | GrowthEPS=+11.0% | GrowthRev=+7.6%
[Analyst] Revisions Ratio: +84% (up=16, down=0)